Merit Medical Systems announced that it intends to offer, subject to market conditions and other factors, $550M aggregate principal amount of convertible senior notes due 2029 in a private placement only to persons reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MMSI:
- Merit Medical price target raised to $96 from $95 at Barrington
- Merit Medical price target lowered to $81 from $96 at Needham
- Merit Medical price target lowered to $88 from $92 at Piper Sandler
- Merit Medical price target raised to $76 from $70 at Canaccord
- Merit Medical raises FY23 EPS view to $2.93-$2.99 from $2.81-$2.92
